Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocol
Fig 3
Cross sectional muscle area of cervical skeletal muscles in a patient with low skeletal muscle mass.